Table 1 Correlation between gene copy number losses by multiplex ligation-dependent probe amplification and clinicopathological features in 135 male breast cancers

TSC2

16p13.3 exon 2

CREBBP

16p13.3 exon 12

ABAT

16p13.2 exon 4

ABCC6

16p13.11exon 13

PALB2

16p12.1 exon 6

VKORC1

16p11.2 exon 1

VPS35

16q11.2 exon 13

ABCC12

16q12.1 exon 28

CYLD

16q12.1 exon 19

0.009

SALL1

16q12.1 exon 3

RBL2

16q12.2 exon 2

0.001

MMP2

16q12.2 exon 14

0.017

SLC12A3

16q13 exon 12

0.02

GPR56

16q13 exon 10

0.009

CDH11

16q22.1 exon 3

CDH11

16q22.1 exon 8

TK2

16q22.1 exon 6

CDH1

16q22.1 exon 1

0.047

CDH1

16q22.1 exon 11

0.021

CDH1

16q22.1 exon 14

ZFHX3

16q22.3 exon 3

WWOX

16q23.1 exon 4

WWOX

16q23.1 exon 10

CDH13

16q23.3 exon 1

MLYCD

16q23.3 exon 2

0.015

MLYCD

16q23.3 exon 3

0.019

IRF8

16q24.1 exon 9

0.017

FOXF1

16q24.1 exon 2

FBXO31

16q24.2 exon 4

SPG7

16q24.3 exon 3

SPG7

16q24.3 exon 4

0.003

FANCA

16q24.3 exon 20

0.006

FANCA

16q24.3 exon 43

GAS8

16q24.3 exon 6